E. Bugianesi

Epidemiology · 2001–2023

A researcher in the Science corpus: 21 papers; trusts 3 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 263 citations into it; #801 of 2,148 by trust here, #85 by citations
• Endocrinology, Diabetes and Metabolism — 161 citations into it
• Pathology and Forensic Medicine — 58 citations into it
• Physiology — 38 citations into it
• Endocrine and Autonomic Systems — 10 citations into it

Whom E. Bugianesi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Giulio Marchesini
2. S. Bellentani
3. J. Dixon
4. A. Sanyal
5. B. Neuschwander‐Tetri
6. E. Brunt

Who trusts E. Bugianesi overall

1. V. Ratziu
2. N. Chalasani
3. J. Clark
4. S. Bellentani
5. Z. Younossi
6. Melania Gaggini
7. K. Cusi
8. B. Neuschwander‐Tetri
9. H. B. EL‐SERAG
10. Giulio Marchesini

Papers from E. Bugianesi's perspective

Ordered by how strongly the researchers E. Bugianesi trusts endorse each paper. Same corpus, a different order for every researcher.

1. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes (Seminars in liver disease (Print))
2. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
3. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. (Journal of Clinical Endocrinology and Metabolism)
4. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference (Hepatology)
5. Metformin reverses fatty liver disease in obese, leptin-deficient mice (Nature Medicine)
6. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis (Hepatology)
7. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss (Hepatology)
8. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease (Hepatology)
9. Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
10. The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)

Their papers

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature (2023) — 2,276 citations
• Global epidemiology of cirrhosis — aetiology, trends and predictions (2023) — 715 citations
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature. (2023) — 2,621 citations
• Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
• NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) — 1,066 citations
• A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) — 3,051 citations
• Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates (2019) — 682 citations
• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (2019) — 1,024 citations
• Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (2019) — 1,574 citations
• Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. (2016) — 645 citations
• Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis (2016) — 799 citations
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease (2013) — 772 citations
• Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease (2010) — 623 citations
• Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes (2008) — 676 citations
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005) — 750 citations
• Insulin resistance: A metabolic pathway to chronic liver disease (2005) — 920 citations
• A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease (2005) — 689 citations
• Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease (2005) — 612 citations
• Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (2003) — 2,737 citations
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. (2002) — 1,293 citations